Hypercortisolemia and Glucocorticoid Receptor-Signaling Insufficiency in Alzheimer’s Disease Initiation and Development

E-ISSN： 1875-5828|10|7|714-731

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.10, Iss.7, 2013-09, pp. : 714-731

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alzheimer’s disease and NGF signaling

By Salehi A. Delcroix J.-D. Swaab D. F.

Journal of Neural Transmission, Vol. 111, Iss. 3, 2004-03 ,pp. : 323-345

Springer Publishing Company

Access to resources Recommend Favorite

Biomarkers to advance drug development for Alzheimer’s disease

By Schulman Howard

Future Neurology, Vol. 1, Iss. 4, 2006-07 ,pp. : 409-415

Future Medicine

Access to resources Recommend Favorite

Alzheimer’s disease

By Gazzaley Adam Small Scott A.

Network: Computation in Neural Systems, Vol. 22, Iss. 1-4, 2011-03 ,pp. : 173-185

Informa Healthcare

Access to resources Recommend Favorite

Development of a PET/SPECT agent for amyloid imaging in Alzheimer’s disease

By Wang Yanming Klunk William Debnath Manik Huang Guo-Feng Holt Daniel Shao Li Mathis Chester

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 55-62

Humana Press, Inc

Access to resources Recommend Favorite

Novel approaches to models of Alzheimer’s disease pathology for drug screening and development

By Shaughnessy Laura Chamblin Beth McMahon Lori Nair Ayyappan Thomas Mary Wakefield John Koentgen Frank Ramabhadran Ram

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 23-32

Humana Press, Inc

Access to resources Recommend Favorite